A new market intelligence report by an ESOMAR certified market research and consulting firm has projected positive growth prospects for the poultry diagnostics market for the assessment period between 2020 and 2030. High consumption of chicken on a global scale and increasingly strict food safety standards in developed countries will held aid growth.
Widespread outbreaks of infectious diseases such as avian influenza is a key factor driving the demand for diagnostic infrastructure in the poultry industry. Also, awareness campaigns by public and private bodies about avian diseases among poultry farmers is positively influencing the industry.
Furthermore, concerns over food security and investments by governments and international bodies towards the intensive farming sector will drive cultivation of poultry. This will also support the demand for poultry diagnostics in the long-term.
Key Takeaways
- ELISA tests are expected to continue holding major market share through 2030, owing to superior accuracy and cost efficiency.
- Diagnostics for avian influenza has been estimated to reflect higher market share on the back of widespread incidences in developing countries.
- Newer ailments such as mortality syndrome are expected to generate lucrative opportunities in terms of product development and interest from the veterinary sector.
- Virology services are expected to be a major contributor to the market owing to higher risk from viral infections for human consumers.
- South Asia and Pacific, will reflect fast growth, with poor hygiene standards in developing nations. North America will continue to hold larger market share, owing to superior infrastructure.
“A rising number of government initiatives towards animal health including investments into associated health information portals are likely to provide impetus to the poultry diagnostics market. Increasingly strict health and safety laws in the poultry industry, especially in developing countries will positively influence the market.,” comments Report Analyst
Insights on the Coronavirus Impact
As the COVID-19 outbreak continues to wreak havoc on the global economy, the poultry diagnostics market is expected to also be adversely impacted during the crisis period. While chickens and other poultry birds are not at risk to the virus, the pandemic is likely to hurt consumption, logistics, and sales of birds. This can be largely attributed to strict regulations on the food service businesses.
These factors are expected to reduce chicken stocks in the poultry industry for the short term, which in turn will reduce the demand for diagnostic tools and infrastructure in the industry. The market is likely to recover strongly towards 2021, as demand for poultry products picks up. Strict food safety laws and concerns over other strains of coronavirus will aid market developments.
Market Competitiveness
Market leaders in the poultry diagnostic industry include but are not limited to Agrobiotek Internacional, Bioneer Corporation, Affinitech Ltd., Zoetis Inc., Biochek, Thermo Fisher Scientific, Bioingentech Biotechnologies Inc., Qiagen N.V., Bionote Inc., Megacor Diagnostik GmbH, and Idexx Laboratories Inc.
Market participants are increasingly focused on the product research with the aim of developing and launching improved testing tools for faster and accurate results. In addition, strategic industry collaborations and acquisitions are being used to build a foundation in a moderately competitive landscape.
In April 2020, BioChek announced the acquisition of BIOTECON, consolidating the company’s presence as a market leader in veterinary PCR-based diagnostic solutions including poultry-industry ailments.
Further, Boehringer Ingelheim and Fraunhofer IME have joined hands towards the development diagnostic and medical animal health products for parasitic ailments.
Also, in August 2020, IDEXX Laboratories released ProCyte One Haematology Analyser for point of care diagnostics in the veterinary industry, including applications in the poultry sector.
These insights are based on a report on Poultry Diagnostics Market by Future Market Insights.